| Identification | |
| Name: | Benzenepropanoic acid, a-hydrazinyl-3,4-dihydroxy-a-methyl-, (aS)- |
| Synonyms: | Benzenepropanoicacid, a-hydrazino-3,4-dihydroxy-a-methyl-, (S)-;Hydrocinnamic acid, a-hydrazino-3,4-dihydroxy-a-methyl-, L- (8CI);(-)-L-a-Hydrazino-3,4-dihydroxy-a-methylhydrocinamic acid;(-)-L-a-Hydrazino-3,4-dihydroxy-a-methylhydrocinnamic acidmonohydrate;1-a-(3,4-Dihydroxybenzyl)-a-hydrazinopropionic acid;Carbidopa;Hydrazino-a-methyldopa;L-3-(3,4-Dihydroxyphenyl)-2-methyl-2-hydrazinopropionic acid;L-a-Hydrazino-3,4-dihydroxy-a-methylbenzenepropanoic acid;L-a-Methyl-a-hydrazino-b-(3,4-dihydroxyphenyl)propionicacid;L-a-Methyldopahydrazine;Lodosyn;MK 486;N-Aminomethyldopa; |
| CAS: | 28860-95-9 |
| EINECS: | 249-271-9 |
| Molecular Formula: | C10H14N2O4 |
| Molecular Weight: | 226.23 |
| InChI: | InChI=1/C10H14N2O4/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6/h2-4,12-14H,5,11H2,1H3,(H,15,16)/t10-/m0/s1 |
| Molecular Structure: |  |
| Properties | |
| Melting Point: | 206 - 208 |
| Density: | 1.42 g/cm3 |
| Solubility: | slightly soluble in water |
| Appearance: | white, crystalline powder |
| Biological Activity: | Peripheral decarboxylase inhibitor, used in combination with levodopa for treatment of Parkinsonism. |
| Usage: | Peripheral inhibitor ofl-aromatic amino acid decarboxylase. When administered simultaneously withl-dopa, it prevents extracerebral conversion to dopamine. |
| Safety Data | |
 |
|
